In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Giancarlo Agnelli
Speaker
Giancarlo Agnelli

Speciality : Pulmonary Circulation-Pulmonary Embolism-Right Heart Failure

15 presentations from this speaker

Exploring NOACs in the management of cancer-associated thrombosis

Congress : ESC Congress 2019

  • Session : Anticoagulation for the management of venous thromboembolism in the non-vitamin K antagonist oral anticoagulant (NOAC) era
  • Speaker : G Agnelli (Perugia,IT)
  • Sponsored by The Bristol-Myers Squibb/Pfizer Alliance

Evolving anticoagulation for venous thromboembolism: focus on patients with cancer.

Congress : ESC Congress 2018

  • Session : Transforming patient care in venous thromboembolism - The role of non-vitamin K antagonist oral anticoagulants
  • Speaker : G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

NOACs for VTE treatment: a change in clinical practice.

Congress : ESC Congress 2017

  • Session : Advancing patient care with NOACs: focus on VTE management
  • Speaker : G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Oral anticoagulation and thrombosis: multidisciplinary perspectives on patient management.

Congress : ESC Congress 2017

  • Session : Oral anticoagulation and thrombosis: multidisciplinary perspectives on patient management
  • Speaker : A Cohen (London,GB), E Hylek (Boston,US), G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Q&A - Advancing patient care with NOACs: focus on VTE management.

Congress : ESC Congress 2017

  • Session : Advancing patient care with NOACs: focus on VTE management
  • Speaker : G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Pulmonary embolism two years after the ESC Guidelines - State of the art

Congress : ESC Congress 2016

  • Session : Tough calls in pulmonary embolism
  • Speaker : G Agnelli (Perugia,IT)

REVERSE II - Discussant review

Congress : ESC Congress 2016

  • Session : Hot Line preventive strategies 2
  • Speaker : G Agnelli (Perugia,IT)

Cancer and venous thromboembolic disease.

Congress : ESC Congress 2015

  • Session : Cardio-oncology
  • Speaker : G Agnelli (Perugia,IT)
  • ESC and the InterAmerican Society of Cardiology

Anticoagulation for thromboembolic diseases: the journey so far.

Congress : ESC Congress 2014

  • Session : Overcoming the dilemma of thrombosis versus bleeding: is this achievable with oral factor Xa inhibition?
  • Speaker : G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

Apixaban for the treatment of venous thromboembolism in cancer patients: Data from the AMPLIFY trial

Congress : ESC Congress 2014

  • Session : Thrombosis and anticoagulation - II
  • Speaker : G Agnelli (Perugia,IT)

Everyday clinical challenges in non-valvular atrial fibrillation and venous thromboembolism: your questions answered.

Congress : ESC Congress 2014

  • Session : The thrombosis versus bleeding risk dilemma: practical considerations with oral factor Xa inhibition
  • Speaker : SH Hohnloser (Frankfurt,DE), J Alexander (Durham,US), G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

The anticoagulation journey continues: panel discussion and conclusion.

Congress : ESC Congress 2014

  • Session : Overcoming the dilemma of thrombosis versus bleeding: is this achievable with oral factor Xa inhibition?
  • Speaker : G Agnelli (Perugia,IT)
  • Sponsored by Bristol-Myers Squibb and Pfizer Alliance

The current use of direct oral anticoagulants (DOACs) for the treatment of VTE in Europe-PREFER in VTE

Congress : ESC Congress 2014

  • Session : Thrombosis: basic mechanisms and clinical management
  • Speaker : G Agnelli (Perugia,IT)

Treatment modalities: anticoagulation, thrombolysis, interventions.

Congress : ESC Congress 2014

  • Session : ESC Guidelines on pulmonary embolism. What is new? What has changed?
  • Speaker : G Agnelli (Perugia,IT)

Risk stratification and clinical management.

Congress : ESC Congress 2013

  • Session : Pulmonary embolism: new therapeutic strategies
  • Speaker : G Agnelli (Perugia,IT)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are